Salic, K., Kleemann, R., Wilkins-Port, C., McNulty, J., Verschuren, L., & Palmer, M. (2019). Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice. PLoS One.
Citação norma ChicagoSalic, Kanita, Robert Kleemann, Cynthia Wilkins-Port, John McNulty, Lars Verschuren, and Melissa Palmer. "Apical Sodium-dependent Bile Acid Transporter Inhibition With Volixibat Improves Metabolic Aspects and Components of Non-alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice." PLoS One 2019.
Citação norma MLASalic, Kanita, et al. "Apical Sodium-dependent Bile Acid Transporter Inhibition With Volixibat Improves Metabolic Aspects and Components of Non-alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice." PLoS One 2019.